RBL2 Antibody, HRP conjugated

1. Three fold reduced Rbl2/p130 expression in these tumor tissues were noticed compared to their control tissues. DNA obtained from MNAse digested chromatin was used as PCR template. PMID: 29417345
2. Hepatitis C virus core protein modulates pRb2/p130 expression in human hepatocellular carcinoma cell lines through promoter methylation PMID: 26576645
3. Statistical analysis revealed that Rbl2/p130 expression negatively correlates to its promoter methylation (r = -0.412) in tumor tissues. PMID: 26271034
4. TGF-beta induced RBL2 expression through down-regulating miR-93 in renal cancer cells PMID: 25183046
5. expression profiling of miRNAs in high-grade serous ovarian carcinoma indicated miR-106a and its family members were upregulated; findings suggest miR-106a can repress expression of the retinoblastoma family member RBL2 and miR-106a overexpression results in rapid tumor growth and poor differentiation PMID: 24045973
6. Low expression of RBL2 is associated with glioma. PMID: 23377830
7. Our hypothesis not only enrich the knowledge of the regulation of ALT, but also indicate that p130 may serve as a potential suppressor of ALT, and gene therapy of p130 may be used in cervical cancers. PMID: 22595804
8. The results show that continued human papillomavirus 16 E6/E7 expression is necessary in cervical cancer cells to prevent cell-cycle arrest by a repressive p130-DREAM complex. PMID: 21813705
9. Hypoproliferation and loss of differentiation in organotypic raft cultures of primary neonatal human foreskin keratinocytes depleted of the alpha and beta isoforms of p63 result from p53-p21-mediated accumulation of retinoblastoma (Rb) family member p130. PMID: 21511729
10. The activity of CTCF in controlling Rb2/p130 gene expression is impaired by BORIS, which by binding to the Rb2/p130 gene could trigger changes in the chromatin asset established by CTCF affecting CTCF regulatory activity on Rb2/p130 transcription. PMID: 21325284
11. Human papillomavirus E7 protein K39,42R mutation moderately increased the association with and the destabilization of p130. PMID: 21411531
12. Gsk3beta, p130 and beta-catenin form in MSC a complex the functional role of which may be associated with activation of differentiation not coupled to cell cycle arrest. PMID: 21516817
13. heterogeneous RB (pRb2 or p16) and p53 (p53, p14, or p21) pathway alterations occur frequently in Burkitt lymphoma PMID: 21127431
14. Loss of p130 accelerates tumor development in a mouse model for human small-cell lung carcinoma. PMID: 20406986
15. FTO influence RBL2 gene expression at large genetic distances PMID: 20009087
16. Data suggest that KSHV miRNA targets multiple pathways to maintain KHSV latency, including repression of the viral protein Rta and a cellular factor, Rbl2, and increased cellular DNMT, in regulating global epigenetic reprogramming. PMID: 20071580
17. The half-life of p130, relative to control cells, was decreased in the cytoplasm in the presence of human papillomavirus 6 E7 or human papillomavirus 16 E7, but only decreased by HPV 6 E7 in the nucleus. PMID: 20189212
18. p130 and its truncated form might substitute Rb in mediating p53-induced cell cycle arrest in Rb(-/-) Saos2 cells PMID: 12386819
19. p130 turnover is regulated by Cdk-dependent G1 phosphorylation leading to ubiquitin-dependent proteolysis PMID: 12435635
20. Expression of this gene predicts outcome in squamous cell carcinoma of the esophagus. PMID: 12474056
21. reduced p130 expression may contribute to the aggressive character of anplastic carcinoma; and p130 may specify the growth characteristics of microcarcinoma PMID: 12637156
22. We investigated occupancy of ER-alpha promoter by pRb2/p130-E2F4/5-HDAC1-SUV39 H1-p300 and pRb2/p130-E2F4/5-HDAC1-SUV39H1-DNMT1 complexes, and provided a link between pRb2/p130 and chromatin-modifying enzymes in the regulation of ER-alpha transcription PMID: 12789259
23. Analysis of gene expression level profiles showed that parental cell line undergoes apoptosis through an E2F1/p73-dependent pathway while its drug resistant variant evades it. PMID: 12789260
24. ATRA mediates growth inhibition by stabilizing Rb2/p130 via a mechanism that involves induction of PP2A, an enzyme that can potentially dephosphorylate Rb2/p130, thereby protecting it from degradation by the proteasome. PMID: 12915404
25. T Ag recruits a phosphatase activity in a DNA J domain-dependent manner to reduce the phosphorylation of p130 PMID: 12968030
26. The interaction between HIV-1 tat and Rb2 may be a possible mechanism in the pathogenesis of AIDS-related lymphoma. PMID: 13679860
27. Rb2/P130 target genes in non-small-cell lung neoplasms are identified by microarray analysis. PMID: 14534545
28. Reduced transcription of the RB2/p130 gene is associated with lung cancer PMID: 14587097
29. pRb2/p130 has a role as a tumour suppressor protein in hepatocellular carcinoma PMID: 15059924
30. pRb2/p130 overexpression is able to arrest cell growth in ovarian carcinoma cells, suggesting the putative role of pRb2/p130 as a tumor suppressor in this malignancy. PMID: 15131049
31. VEGF together with pRb2/p130 may have a role in hepatocellular carcinoma in a p27((KIP1))-independent manner PMID: 15161709
32. Disruption of E2F4 through small interfering RNA prevented p130/E2F4 complex formation and sensitized prostate cancer cells to IR-induced apoptosis. PMID: 15231644
33. Rb2/ p130 expression can additionally be an indicator of a better prognosis in patients with gliomas PMID: 15696973
34. RBP2 resembles other chromatin-associated transcriptional regulators and RBP2 binding to activate transcription and promote differentiation. PMID: 15949438
35. p130 is a trancriptional regulator of the cell cycle genes. PMID: 16135806
36. Involved in progression and regulation of telomerase PMID: 16364039
37. ER-beta and pRb2/p130 proteins co-immunoprecipitate in both nucleus and cytoplasm of MCF-7 breast cancer cells. The interaction of pRb2/130 with ER-beta may have a functional significance in regulating ER-beta activity. PMID: 16760287
38. All-trans-retinoic acid (ATRA) has been shown to arrest the growth of ovarian carcinoma cells in G0/G1 and to significantly elevate levels of Rb2/p130 protein. (review) PMID: 16936753
39. supportive role in the genesis of retinoblastoma has recently been proposed for the RB1-related gene RB2/p130. (review) PMID: 16936755
40. Mutated RBL2 is associated with Burkitt lymphoma PMID: 17485552
41. Evolutionarily conserved multisubunit protein complex that contains p130 and E2F4 mediates the repression of cell cycle-dependent genes in quiescence. PMID: 17531812
42. no mutation of p53 and RB2/p130 genes was identified in any of the blood samples from Malaysian nasopharyngeal carcinoma PMID: 17694957
43. There was a strong correlation between the expression of p130 in Stage 1 & 3, but not Stage 2, tumors. High levels of p130 were detected in the cytoplasm rather than the nucleus, suggesting an aberrant subcellular localization of this tumor suppressor. PMID: 17905135
44. Collectively, these data support the notion that p130 controls the homeostasis of the differentiated keratinocytes and is therefore targeted by E7 for degradation to establish conditions permissive for viral DNA amplification. PMID: 18321970
45. P130 may be required to prevent the onset of terminal growth arrest in unstimulated prostate cancer cells lacking a functional Rb allele. PMID: 18418057
46. It is possible that a hyperphosphorylated form of Rb2/p130 may contribute to the resistance of ovarian carcinoma cells to ATRA mediated growth suppression PMID: 18446820
47. pRb2/p130 has a role in reducing survival in human soft tissue sarcomas PMID: 18676747
48. Loss of heterozygosity within RBL2/p130 gene is associated with retinoblastoma. PMID: 19252413
49. pRb2/p130 was mainly localized in the cytoplasm rather than in the nucleus in rectal cancer. PMID: 19597825
50. Data suggest that Rb2/p130 is a member of the p53-p21 DNA damage signaling cascade, and represents the essential pocket protein family member needed for the induction of any type of senescence. PMID: 19648966

Show More

Hide All

HGNC: 9894

OMIM: 180203

KEGG: hsa:5934

STRING: 9606.ENSP00000262133

UniGene: Hs.513609